TY  - JOUR
T1  - In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group Strains
A1  - Betriu, Carmen
LA  - en
PB  - American Society for Microbiology
YR  - 2001
UL  - http://buscaintegrada.pucsp.br/vufind/Record/pubmed-90657
AB  - The activity of MK-0826, a new carbapenem, against 309 Bacteroides fragilis group strains was investigated and compared with that of 11 other β-lactam and 5 non-β-lactam agents. MK-0826 showed excellent activity (MICs ranged from ≤0.06 to 4 μg/ml). The new carbapenem may be useful in the treatment of mixed anaerobic infections involving B. fragilis group strains.
KW  - Susceptibility
ER  -